(Q41418810)
Statements
1 reference
Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study (English)
1 reference
D A Isenberg
1 reference
M Petri
1 reference
K Kalunian
1 reference
Y Tanaka
1 reference
M B Urowitz
1 reference
R W Hoffman
1 reference
M Morgan-Cox
1 reference
N Iikuni
1 reference
M Silk
1 reference
D J Wallace
1 reference
3 September 2015
1 reference
1 reference
75
1 reference
2
1 reference
323-331
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference